[go: up one dir, main page]

DK1017408T3 - Anvendelse af tetrahydrolipstatin i behandling af diabetes type II - Google Patents

Anvendelse af tetrahydrolipstatin i behandling af diabetes type II

Info

Publication number
DK1017408T3
DK1017408T3 DK98908008T DK98908008T DK1017408T3 DK 1017408 T3 DK1017408 T3 DK 1017408T3 DK 98908008 T DK98908008 T DK 98908008T DK 98908008 T DK98908008 T DK 98908008T DK 1017408 T3 DK1017408 T3 DK 1017408T3
Authority
DK
Denmark
Prior art keywords
tetrahydrolipstatin
diabetes
treatment
type
Prior art date
Application number
DK98908008T
Other languages
Danish (da)
English (en)
Inventor
Jonathan Brian Hauptman
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21894047&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1017408(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK1017408T3 publication Critical patent/DK1017408T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK98908008T 1997-02-05 1998-01-29 Anvendelse af tetrahydrolipstatin i behandling af diabetes type II DK1017408T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3738397P 1997-02-05 1997-02-05
EP98908008A EP1017408B1 (en) 1997-02-05 1998-01-29 Use of tethrahydrolipstatin in the treatment of diabetes type ii
PCT/EP1998/000468 WO1998034630A1 (en) 1997-02-05 1998-01-29 Use of gastrointestinal lipase inhibitors

Publications (1)

Publication Number Publication Date
DK1017408T3 true DK1017408T3 (da) 2005-08-01

Family

ID=21894047

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98908008T DK1017408T3 (da) 1997-02-05 1998-01-29 Anvendelse af tetrahydrolipstatin i behandling af diabetes type II

Country Status (28)

Country Link
US (1) US6147108A (no)
EP (1) EP1017408B1 (no)
JP (1) JP2001509173A (no)
KR (1) KR100479968B1 (no)
CN (1) CN1154505C (no)
AR (1) AR011106A1 (no)
AT (1) ATE292975T1 (no)
AU (1) AU740375B2 (no)
BR (1) BR9807655A (no)
CA (1) CA2278854C (no)
CZ (1) CZ295567B6 (no)
DE (1) DE69829763T2 (no)
DK (1) DK1017408T3 (no)
ES (1) ES2239799T3 (no)
HK (1) HK1025251A1 (no)
HU (1) HU230834B1 (no)
ID (1) ID22650A (no)
IL (1) IL131007A0 (no)
ME (1) ME00578A (no)
NO (1) NO324452B1 (no)
NZ (1) NZ336755A (no)
PL (1) PL191222B1 (no)
PT (1) PT1017408E (no)
RU (1) RU2201272C2 (no)
TR (1) TR199901853T2 (no)
WO (1) WO1998034630A1 (no)
YU (1) YU34199A (no)
ZA (1) ZA98753B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1017408T3 (da) * 1997-02-05 2005-08-01 Hoffmann La Roche Anvendelse af tetrahydrolipstatin i behandling af diabetes type II
AR025587A1 (es) * 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
AR025609A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones lipidas solidas
ES2324280T3 (es) 2000-03-14 2009-08-04 Unilever N.V. Dominios variables de la cadena pesada de anticuerpos frente a lipasas dieteticas humanas y sus usos.
US7060675B2 (en) 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US6867183B2 (en) 2001-02-15 2005-03-15 Nobex Corporation Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7196059B2 (en) 2001-09-07 2007-03-27 Biocon Limited Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
WO2003105768A2 (en) 2002-06-13 2003-12-24 Nobex Corporation Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
US9174176B2 (en) 2003-01-09 2015-11-03 Disperse Systems, Inc. Ultrasonic dispersion apparatus, system, and method
US7510849B2 (en) * 2004-01-29 2009-03-31 Glucolight Corporation OCT based method for diagnosis and therapy
CN101027318B (zh) 2004-07-19 2016-05-25 比奥孔有限公司 胰岛素-低聚物共轭物，制剂及其用途
US8036727B2 (en) 2004-08-11 2011-10-11 Glt Acquisition Corp. Methods for noninvasively measuring analyte levels in a subject
US7254429B2 (en) * 2004-08-11 2007-08-07 Glucolight Corporation Method and apparatus for monitoring glucose levels in a biological tissue
EP1874178A4 (en) 2005-04-13 2009-12-09 Glucolight Corp METHOD OF DECREASING AND CALIBRATION OF DATA OF A CROSS-REFERENCE OF A BLOOD GLUCOMETER BASED ON OPTICAL COHERENCE TOMOGRAPHY AND RELATED APPLICATIONS
US8217025B2 (en) * 2006-11-17 2012-07-10 Harbor Therapeutics, Inc. Drug screening and treatment methods
ATE477820T1 (de) * 2007-09-12 2010-09-15 Mader S R L Pharmazeutische zusammensetzungen zur oralen verabreichung bei der behandlung von adipositas- patienten
WO2009050720A1 (en) * 2007-10-15 2009-04-23 Inventis Dds Pvt Limited Pharmaceutical composition of orlistat
CN101939023B (zh) 2007-10-16 2016-08-03 百康有限公司 可经口给药的固体药物组合物及其方法
US8571617B2 (en) 2008-03-04 2013-10-29 Glt Acquisition Corp. Flowometry in optical coherence tomography for analyte level estimation
US8309107B2 (en) * 2008-10-06 2012-11-13 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
FR3017536B1 (fr) * 2014-02-18 2017-05-26 Univ La Rochelle Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase
CN109414414A (zh) 2016-03-16 2019-03-01 戴维·格拉德斯通研究所 用于治疗肥胖症和/或糖尿病以及用于鉴定候选治疗剂的方法和组合物
WO2019018849A1 (en) * 2017-07-21 2019-01-24 Kieu Hoang STATINES (ATORVASTATIN) THAT CAN REDUCE GLYCEMIA LEVEL IN DIABETICS

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
CA1328881C (en) * 1984-12-21 1994-04-26 Pierre Barbier Process for the manufacture of oxetanones
CA1270837A (en) * 1984-12-21 1990-06-26 Hoffmann-La Roche Limited Oxetanones
CA2035972C (en) * 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
US5190970A (en) * 1990-10-19 1993-03-02 E. R. Squibb & Sons, Inc. Method for preventing onset of or treating Type II diabetes employing a cholesterol lowering drug alone or in combination with an ace inhibitor
US5130333A (en) * 1990-10-19 1992-07-14 E. R. Squibb & Sons, Inc. Method for treating type II diabetes employing a cholesterol lowering drug
US5345056A (en) * 1991-12-12 1994-09-06 Motorola, Inc. Plasma based soldering by indirect heating
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
CA2128044C (en) * 1993-08-05 2007-02-20 Klaus-Dieter Bremer Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor
JP3532999B2 (ja) * 1995-03-24 2004-05-31 株式会社ロッテ 新規なタンニン類およびこれを有効成分とするリパーゼ阻害剤
JPH09227398A (ja) * 1996-02-20 1997-09-02 Zeria Pharmaceut Co Ltd 抗肥満剤
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
DK1017408T3 (da) * 1997-02-05 2005-08-01 Hoffmann La Roche Anvendelse af tetrahydrolipstatin i behandling af diabetes type II

Also Published As

Publication number Publication date
NO993717D0 (no) 1999-07-30
NO324452B1 (no) 2007-10-22
NO993717L (no) 1999-10-04
RU2201272C2 (ru) 2003-03-27
AU740375B2 (en) 2001-11-01
ATE292975T1 (de) 2005-04-15
NZ336755A (en) 2001-06-29
YU34199A (sh) 2002-08-12
EP1017408A1 (en) 2000-07-12
WO1998034630A1 (en) 1998-08-13
CA2278854A1 (en) 1998-08-13
ZA98753B (en) 1998-08-05
CZ265199A3 (cs) 2000-02-16
US6147108A (en) 2000-11-14
KR100479968B1 (ko) 2005-03-30
KR20000070733A (ko) 2000-11-25
EP1017408B1 (en) 2005-04-13
AU6616998A (en) 1998-08-26
DE69829763T2 (de) 2006-04-13
HK1025251A1 (en) 2000-11-10
PL334975A1 (en) 2000-03-27
CZ295567B6 (cs) 2005-08-17
ME00578A (en) 2011-12-20
IL131007A0 (en) 2001-01-28
BR9807655A (pt) 2000-02-15
TR199901853T2 (xx) 1999-12-21
CA2278854C (en) 2014-03-04
CN1246798A (zh) 2000-03-08
HUP0001014A3 (en) 2000-12-28
ID22650A (id) 1999-12-02
CN1154505C (zh) 2004-06-23
HUP0001014A2 (hu) 2000-08-28
PT1017408E (pt) 2005-07-29
JP2001509173A (ja) 2001-07-10
ES2239799T3 (es) 2005-10-01
PL191222B1 (pl) 2006-03-31
AR011106A1 (es) 2000-08-02
HU230834B1 (hu) 2018-07-30
DE69829763D1 (de) 2005-05-19

Similar Documents

Publication Publication Date Title
DK1017408T3 (da) Anvendelse af tetrahydrolipstatin i behandling af diabetes type II
TR199501053A2 (tr) Tedavide yararli spiro-azabisiklik bilesikler.
DE59709443D1 (de) Blutpumpe
NO2006014I1 (no) Insulin glulisin
DE69822059D1 (de) Wegwerfwindel
DE69828931D1 (de) Wegwerfwindel
ID17315A (id) Perekat yang dapat digabungkan secara hayati
DE69825982D1 (de) Spritze
DE69431204D1 (de) Blutpumpe
DE69826619D1 (de) Wegwerfwindel
NO983266D0 (no) Distribuert Behandling
DE69823360D1 (de) Feste arzneizubereitung enthaltend benzofuranderivate
IS5504A (is) Samsetning virk við meðhöndlun á getuleysi
DE69821187D1 (de) Wegwerfwindel
EP0996433A4 (en) Methods for treatment of conditions associated with lactosylceramide
ID15967A (id) Agen terapi diabetes
DE69807225D1 (de) Vliesstoffbehandlung
DK0903130T3 (da) Forbedringer i forbindelse med ostomiindretninger
DE69803120D1 (de) Wegwerfwindel
DE59810482D1 (de) Schleifen von garnituren
NO983263L (no) Distribuert behandling
FI974244A0 (fi) Foerfarande foer kompressering av en bild
NO995492D0 (no) Algicider
IS5324A (is) (S) 2-Metýlamínó-2-fenýl-n-bútýl 3,4,5-trímetoxý-bensóat, notkun þess til meðferðar á langvinnum sársauka
DE59811085D1 (de) Oszillatorschaltungsanordnung